Ligand design and synthesis of new imidazo[5,1-b]quinazoline derivatives as alpha1-adrenoceptor agonists and antagonists. 2006

Mohamed A H Ismail, and Mohamed N Y Aboul-Enein, and Khaled A M Abouzid, and Rabah A T Serya
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt. mhismaeel@hotmail.com

A series of new imidazo[5,1-b]quinazoline derivatives (VII-IX) was designed, synthesized, and biologically evaluated for their in vivo hypotensive or hypertensive activities. The design of these compounds was based upon the molecular modeling simulation of the fitting values and conformational energy values of the best-fitted conformers to both the alpha(1)-adrenoceptor (alpha(1)-AR) agonist and alpha(1)-adrenoceptor (alpha(1)-AR) antagonist hypotheses. These hypotheses were generated from their corresponding lead compounds using CATALYST software. The simulation studies predicted that compounds IXa and IXe would have probable affinity for the alpha(1)-AR antagonist hypothesis, while compounds IXb, IXc, and IXg predicted a higher affinity for the alpha(1)-AR agonist hypothesis. In vivo biological evaluation of these compounds for their effects on the blood pressure of normotensive cats was consistent with the results of molecular modeling studies, where compounds IXa and IXe exhibited hypotensive activity, while compounds IXb, IXc, and IXg resulted in increasing the blood pressure of the experimental animals at different doses.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002384 Catalysis The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction. Catalyses
D002415 Cats The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801) Felis catus,Felis domesticus,Domestic Cats,Felis domestica,Felis sylvestris catus,Cat,Cat, Domestic,Cats, Domestic,Domestic Cat
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Mohamed A H Ismail, and Mohamed N Y Aboul-Enein, and Khaled A M Abouzid, and Rabah A T Serya
January 2000, Bioorganic & medicinal chemistry,
Mohamed A H Ismail, and Mohamed N Y Aboul-Enein, and Khaled A M Abouzid, and Rabah A T Serya
August 2002, Journal of medicinal chemistry,
Mohamed A H Ismail, and Mohamed N Y Aboul-Enein, and Khaled A M Abouzid, and Rabah A T Serya
January 2002, Cancer research,
Mohamed A H Ismail, and Mohamed N Y Aboul-Enein, and Khaled A M Abouzid, and Rabah A T Serya
September 1991, Farmaco (Societa chimica italiana : 1989),
Mohamed A H Ismail, and Mohamed N Y Aboul-Enein, and Khaled A M Abouzid, and Rabah A T Serya
March 2006, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Mohamed A H Ismail, and Mohamed N Y Aboul-Enein, and Khaled A M Abouzid, and Rabah A T Serya
February 2021, Bioorganic & medicinal chemistry letters,
Mohamed A H Ismail, and Mohamed N Y Aboul-Enein, and Khaled A M Abouzid, and Rabah A T Serya
July 2000, Bioorganic & medicinal chemistry,
Mohamed A H Ismail, and Mohamed N Y Aboul-Enein, and Khaled A M Abouzid, and Rabah A T Serya
December 2009, Naunyn-Schmiedeberg's archives of pharmacology,
Mohamed A H Ismail, and Mohamed N Y Aboul-Enein, and Khaled A M Abouzid, and Rabah A T Serya
February 2011, Bioorganic & medicinal chemistry letters,
Mohamed A H Ismail, and Mohamed N Y Aboul-Enein, and Khaled A M Abouzid, and Rabah A T Serya
January 2018, Iranian journal of pharmaceutical research : IJPR,
Copied contents to your clipboard!